radioiodine

The secondary hypothyroidism after radioiodine therapy and the replacement treatment

~（131）I治疗甲亢后的继发甲减及替代治疗

Preparation and performance study of impregnated charcoal used for removing gaseous radioiodine

浸渍活性炭的制备及其捕集气态放射性碘的研究

Diffuse radioiodine lung uptake in~ ( 131) iodine whole body scan: case report

~（131）碘全身显像双肺弥漫性显影1例

Dynamic Changes of Serum Levels of TGA and TMA and the Clinical Significance After Radioiodine Treatment for Patients with Graves' Disease

Graves病患者放射性碘治疗后TGA，TMA的动态变化及临床意义

The radioiodine therapy and the TSH suppressive therapy shall be applied postoperatively, in order to increase effectiveness.

术后再配合131I治疗及促甲状腺激素（TSH）抑制治疗可提高疗效。

Study of radioiodine combined with herbs on Graves' disease

同位素Na~（131）I联合中草药治疗Graves病的研究

Objective: To analyze the factors affecting thyroid radioiodine uptake ( RAIU) of hyperthyroidism patients.

目的：分析甲亢患者甲状腺摄131I率峰值的影响因素。

After treated with modified therapeutic strategy ( radioiodine therapy or operation), the non-remission patients get a better curative effect.

未缓解组患者，经临床及时更改治疗方法（放射性碘治疗或手术治疗），均获得了较好的疗效。

CONCLUSION: Radioiodine thyroid uptake ratio of tracer dose can reflect completely that of therapeutic dose.

结论：甲状腺功能仪测定的示踪剂量24h摄131I率完全反映治疗剂量甲状腺摄131I率；

Comparison of the Radioiodine Thyroid Uptake of Diagnostic Dose and Therapeutic Dose in Patients with Hyperthyroidism

甲亢患者诊断剂量和治疗剂量~（131）I摄取率的比较研究

Objective To investigate effect of radioiodine therapy on pulmonary metastases from well-differentiated thyroid cancer.

目的探讨131I治疗分化型甲状腺癌肺转移对肺功能的影响。

Ultrafiltration is suitable for purification of the radioiodine labeled protein.

离心超滤技术适合放射性碘标记蛋白质的纯化。

Efficacy analysis of first radioiodine ablation of residual thyroid tissue in postoperative patients with thyroid cancer

甲状腺癌术后~（131）I首次清除剩余甲状腺疗效分析

Study on the mechanism of removal of radioiodine with silica gels impregnated with silver nitrate

附银硅胶除碘的机理研究

The clinical analysis of 105 patients with thyrotoxic cardiopathy treated with radioiodine

~（131）I治疗甲亢性心脏病105例分析

The secondary hypothyroidism is the most important intercurrent disease after radioiodine therapy.

继发性甲状腺功能减退症（甲减）是131I治疗甲状腺功能亢进症（甲亢）后最重要的并发症。

Nearly 60 years practice has proven that radioiodine is safe and effective and should be the first, line therapy.

近60年的医疗实践证明，131I治疗是安全、有效的，应当作为首选治疗方法。

Dynamic Changes and Clinical Significance of Thyroid Auto-antibodies Before and After Radioiodine Treatment for Graves' Disease

Graves病~（131）I治疗前后甲状腺自身抗体的变化及其临床意义

Study of biological effects of radioiodine and its medical protection

放射性碘生物危害及其医学防护的研究

Investigation of adsorption properties of the silver nitrate impregnated silica gels for radioiodine

附银硅胶对碘的吸附特性的研究

Conclusion: The rate of radioiodine uptake by the thyroid cancer cells is negatively correlated with the irradiation dosage.

结论：放射性131I照射可以使分化型甲状腺癌细胞摄碘率显著降低。

Primary Study of Imaging Apoptosis with Radioiodine Labeled-Annexin V

放射性碘标记Annexin V进行体内凋亡显像的研究

AIM: To compare early radioiodine thyroid uptake ratio between tracer and therapeutic dose with different methods.

目的：用不同方法比较示踪剂量与治疗剂量131I早期摄取率，为临床治疗甲状腺功能亢进症提供依据。

A study of the adsorption properties of the silver nitrate impregnated Mordenite for airborne radioiodine

附银丝光沸石对气载放射性碘的吸附特性的研究

Antithyroid drugs, again radioiodine therapy and surgery, are the treatments.

其治疗方法有抗甲状腺药物治疗、再次放射性~（131）I治疗、手术治疗。

The structural features and testing results of the technical properties of DQ 2 type airborne radioiodine sampler are introduced.

本文主要介绍了DQ2型气载放射性碘采样器的结构特点和技术性能的测试结果。

The principal aim of this study was to compare radioiodine treatment and medical therapy for long-term worsening or development of TAO.

该项研究旨在比较碘放疗与内科治疗对TAO的发生和长期恶化影响。

Comparison of early radioiodine thyroid uptake ratio of therapeutic dose in different methods

治疗剂量~（131）I早期摄取率检测方法比较

Retention pattern of radioiodine in rat thyroid and its dose evaluation

放射性碘在大鼠甲状腺内的滞留模式及剂量估算

Study on the stability of radioiodine-labeled porcine zona pellucida antigen

碘标记猪卵透明带抗原的稳定性研究